KCM Investment Advisors LLC Sells 209 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

KCM Investment Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,164 shares of the medical equipment provider’s stock after selling 209 shares during the quarter. KCM Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,063,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Empowered Funds LLC raised its stake in shares of Intuitive Surgical by 4.4% in the third quarter. Empowered Funds LLC now owns 8,177 shares of the medical equipment provider’s stock worth $4,017,000 after acquiring an additional 345 shares during the last quarter. Empirical Finance LLC increased its holdings in shares of Intuitive Surgical by 2.3% in the third quarter. Empirical Finance LLC now owns 12,106 shares of the medical equipment provider’s stock valued at $5,947,000 after purchasing an additional 269 shares in the last quarter. Sheaff Brock Investment Advisors LLC bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $5,910,000. CIBC Asset Management Inc lifted its holdings in Intuitive Surgical by 5.3% during the 3rd quarter. CIBC Asset Management Inc now owns 189,822 shares of the medical equipment provider’s stock worth $93,254,000 after buying an additional 9,524 shares in the last quarter. Finally, FUKOKU MUTUAL LIFE INSURANCE Co boosted its position in Intuitive Surgical by 2.6% in the 3rd quarter. FUKOKU MUTUAL LIFE INSURANCE Co now owns 2,207 shares of the medical equipment provider’s stock valued at $1,084,000 after buying an additional 56 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now owns 1,595 shares of the company’s stock, valued at $757,625. The trade was a 15.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 238 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $477.50, for a total value of $113,645.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,629,115. The trade was a 4.14 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 91,178 shares of company stock worth $45,897,071. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several research reports. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Raymond James lifted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Stock Down 1.9 %

Shares of NASDAQ:ISRG opened at $527.61 on Friday. The firm has a market cap of $187.92 billion, a price-to-earnings ratio of 84.82, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $295.02 and a 12 month high of $544.38. The company’s fifty day simple moving average is $499.29 and its 200 day simple moving average is $457.28.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.